Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9062)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2019 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ozyigit G, Hurmuz P, Yuce D, Akyol F. Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. World J Clin Oncol 2019; 10(8): 283-292 [PMID: 31528544 DOI: 10.5306/wjco.v10.i8.283] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i8/283.htm |
| Number | Citing Articles |
| 1 |
Monique Barnard, Elahe A. Mostaghel, Richard J. Auchus, Karl-Heinz Storbeck. The role of adrenal derived androgens in castration resistant prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 2020; 197: 105506 doi: 10.1016/j.jsbmb.2019.105506
|
| 2 |
Juan Morote. The importance of appropriate castrate level measurements of serum testosterone in prostate cancer patients. Radiotherapy and Oncology 2022; 169: 150 doi: 10.1016/j.radonc.2022.01.028
|
| 3 |
Almudena Zapatero, Ana Álvarez, Araceli Guerrero, Xavier Maldonado, Carmen González San Segundo, María A. Cabeza, Carmen Martín de Vidales, Josep M. Solé, Agustí Pedro Olivé, Francesc Casas, Ana Boladeras, María L. Vázquez de la Torre, Susana Vara, Felipe.A. Calvo. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial. Radiotherapy and Oncology 2021; 160: 115 doi: 10.1016/j.radonc.2021.04.018
|
| 4 |
T. Raja, Rahul Sud, Sanjai Addla, Kalyan K. Sarkar, P.S. Sridhar, Vikas Talreja, Minish Jain, Ketaki Patil. Gonadotropin-releasing hormone agonists in prostate cancer. Indian Journal of Cancer 2022; 59(Suppl 1): S142 doi: 10.4103/ijc.IJC_65_21
|
| 5 |
Adriana Aguilar, Jacques Planas, Enrique Trilla, Juan Morote. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review. Cancers 2023; 15(13): 3479 doi: 10.3390/cancers15133479
|
| 6 |
Ganesh Bakshi, Hemant Tongaonkar, Sanjai Addla, Santosh Menon, Aditya Pradhan, Abhay Kumar, Abhijit Bapat, Adwaita Gore, Amit Joshi, Anand Raja, Anil Bradoo, Anita Ramesh, Anup Kumar, Archi Agrawal, Asawari Ambekar, Ashish Joshi, Ashish Singh, Bhupendra Pal Singh, Deepak Dabkara, Dhiraj Khadakban, Gagan Gautam, Gagan Prakash, Harvinder Singh Pahwa, Hemant Kumar Goel, Jagdeesh Kulkarni, Jeeban Jyoti Mishra, Kaushal Patel, Mahendra Pal, Percy J Chibber, Priya Tiwari, Radheshyam Naik, S K Raghunath, Rahul Krishnatry, Rajendra Shimpi, Rakesh Sharma, Rakesh Taran, Sameer Trivedi, Sanjay Nabar, Sanjoy Surekha, Satish Kumar, Satyakam Krishna Sawaimoon, Shailesh Raina, Srivatsa Narasimha, Suresh Advani, Syed Mohammed Ghouse, Vamshi Krishna Muddu, Vashishth Maniar, Vivek Venkat, Vedang Murthy. Expert survey on management of prostate cancer in India. Indian Journal of Cancer 2022; 59(Suppl 1): S19 doi: 10.4103/ijc.ijc_1145_21
|
| 7 |
Nardana Bazybek, Yi Wei, Guanghui Ma. Advances in encapsulating gonadotropin-releasing hormone agonists for controlled release: a review. Journal of Microencapsulation 2022; 39(5): 452 doi: 10.1080/02652048.2022.2100934
|